In conclusion, here we described for the first time an integrated signaling module that links liver steatosis and the activation of IL6/STAT3 signaling with downstream STAT3-dependent activation of a number of miRNAs, including the onco-mir miR-21. This evidence concerns the gene IL6 and fatty liver disease.